Osteoporosis in frail older adults: recommendations for research from the ICFSR task force 2020

Authors: ROLLAND, YVES - Toulouse University Hospital; CESARI, MATTEO - University Of Milan; FIELDING, ROGER - Jean Mayer Human Nutrition Research Center On Aging At Tufts University; REGINSTER, J.Y. - University Of Liege; VELLAS, BRUNO - Toulouse University Hospital; CRUZ-JENTOFT, ALFONSO - Hospital Ramon Y Cajal

Submitted to: The Journal of Frailty and Aging
Publication Type: Other
Publication Acceptance Date: 9/21/2020
Publication Date: 2/7/2021
Citation: Rolland, Y., Cesari, M., Fielding, R., Reginster, J., Vellas, B., Cruz-Jentoft, A.J. 2021. Osteoporosis in frail older adults: recommendations for research from the ICFSR task force 2020. The Journal of Frailty and Aging. https://doi.org/10.14283/jfa.2021.4.
DOI: https://doi.org/10.14283/jfa.2021.4

Interpretive Summary:

Technical Abstract: Interactions among physiological pathways associated with osteoporosis and sarcopenia are thought to contribute to the onset of frailty. The International Conference on Frailty and Sarcopenia Research Task Force thus met in March 2020 to explore how emerging interventions to manage fracture and osteoporosis in older adults may reduce frailty, disability, morbidity, and mortality in the older population. Both pharmacological and non-pharmacological interventions (including nutritional intervention, exercise, and other lifestyle changes) were discussed, including nutritional intervention, exercise, and other lifestyle changes. Pharmacological treatments for osteoporosis include bone-forming and antiresorptive agents, which may optimally be used in sequential or combination regimens. Since similar mechanisms related to resorption underlie physiological changes in muscle and bone, these interventions may provide benefits beyond treating osteoporosis. Clinical trials to test these interventions, however, often exclude frail older persons because of comorbidities (such as mobility disability and cognitive impairment) or polypharmacy. The Task Force recommended that future clinical trials use harmonized protocols, including harmonized inclusion criteria and similar outcome measures; and that they test a range of multidomain therapies. They further advocated more high-quality research to develop interventions specifically for people who are frail and old. The ICOPE program recommended by WHO appears to be highly recommended to frail older adults with osteoporosis.